Detecting neurodegenerative diseases
Parkinson's disease and other neurodegenerative diseases undergo a multiple
decade long process on a molecular level before their first clinical symptoms
arise. In fact, 15-20 years before any clinical symptoms, molecular changes can
be observed in the brain through the misfolding of protein biomarkers.
With betaSENSE’s platform technology, we can precisely monitor and quantify
this process in body fluids
Company Details
- Employees
- 23
- Founded
- 2021
- Address
- Universitätsstraße 136, Bochum,north Rhine-Westphalia 44799,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.beta-sense.de/
- Keywords
- Parkinson, ALS, Alzheimer, Proteindiagnostik, Neurodegenerative Krankheiten, Blutbasierte Diagnostik.
- HQ
- Bochum, North Rhine-Westphalia
Betasense Questions
Betasense's website is https://www.beta-sense.de/
Betasense's LinkedIn profile is https://de.linkedin.com/company/betasense
Betasense has
23 employees.
View email and phone details for 23
employees at Betasense.
Betasense's industry is
Biotechnology Research
Betasense's top competitors are
Optek-Danulat,
Lead Discovery Center Gmbh,
Tradevest,
Mukocell Gmbh,
Margarete Steiff Gmbh,
Noselab,
Steiff North America, Inc.,
Snap Discovery,
Temicon Gmbh,
Novasign.
Betasense's categories are Biotechnology Research
Betasense's founding year is 2021
